1-8 of 8
Giora Sharf
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Asciminib Shows High Efficacy and Favorable Tolerability at 80 Mg Once Daily and 40 Mg Twice Daily in Patients with Chronic Phase Chronic Myelogenous Leukemia Previously Treated with 2 or More Tyrosine Kinase Inhibitors: Primary Analysis from the ASC4OPT Study

Andreas Hochhaus, Philipp le Coutre, Dragana Milojkovic, Dennis Dong Hwan Kim, Soo Min Lim, Carolina Pavlovsky, Thanh HA Nguyen, Franck E. Nicolini, Beatriz Moiraghi, Sebastian Grosicki, Chi Dung Phu, Gabriel Etienne, Fernando Marco De Lucas, Rosa Ayala, Massimo Breccia, Charles Chuah, Giora Sharf, Roberto Abi Rached, Himanshu Pokhriyal, Santoshkumar Tota, Asmae Mirkou, Peter Schuld, Carla Boquimpani
Journal: Blood
Blood (2024) 144 (Supplement 1): 4526.
https://doi.org/10.1182/blood-2024-200017
Published: 2024
Journal Articles

Health-Related Quality of Life in Chronic Lymphocytic Leukemia Patients in Active Surveillance and Active Treatment in Israel

Tamar Tadmor, Bushra Mahameed, Giora Sharf, Geffen Kleinstern
Journal: Blood
Blood (2023) 142 (Supplement 1): 6525.
https://doi.org/10.1182/blood-2023-181519
Published: 2023
Journal Articles

ASC4OPT: A Phase 3b Open-Label Optimization Study of Oral Asciminib in Chronic Myelogenous Leukemia in Chronic Phase Previously Treated with 2 or More Tyrosine Kinase Inhibitors

Massimo Breccia, Anna Turkina, Carla Boquimpani, Charles Chuah, Giora Sharf, Luigi Di Caprio, Matthias Hoch, Justin Yssel, Yifan Zhang, Andreas Hochhaus
Journal: Blood
Blood (2022) 140 (Supplement 1): 9635–9636.
https://doi.org/10.1182/blood-2022-157991
Published: 2022
Journal Articles

Clinical & Economic Implications of Hydroxyurea Intolerance in Polycythemia Vera in Routine Clinical Practice in Israel

Martin H. Ellis, MD, Tamar Tadmor, MD, Gabriel Chodick, PhD, Naama Yekutiel, MSc, Moti Levi, Giora Sharf, Oren Feine, PhD, Raanan Leef, BSc, MBA, Nana Ben Zvi, MD, Oren Shavit, PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 23–24.
https://doi.org/10.1182/blood-2020-141821
Published: 2020
Journal Articles

CML Patients' Views on Psychological Support throughout the Treatment-Free Remission Journey

Giora Sharf, Andreas Hochhaus, MD, Jan Geissler, Celia Marin, Zack Pemberton-Whiteley, Felice Bombaci, Rita I O Christensen, Bahija Gouimi, Mina Daban, Nigel B Deekes, Jennie Bradley
Journal: Blood
Blood (2019) 134 (Supplement_1): 2934.
https://doi.org/10.1182/blood-2019-123942
Published: 2019
Journal Articles

Patient Reported Outcomes (PROs) Show Superior Quality of Life (QOL) of Patients with Chronic Myeloid Leukemia (CML) Treated with First Compared to Newer Generations of Tyrosine Kinase Inhibitors (TKIs)

Adi Shacham, MD, Lena Rosenman, Avi Leader, MD, Giora Sharf, Pia Raanani, MD, Uri Rozovski, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4781.
https://doi.org/10.1182/blood-2019-129806
Published: 2019
Journal Articles

T he Effect of A dherence-Encouraging Interventions on Adherence to Tyrosine K inas e I nhibitor T reatment in Chronic Myeloid Leukemia ( TAKE-IT ): A Pre-Post Intervention Pilot Study

Avi Leader, MD, Noam Benyamini, MD, Sabina De Geest, PhDRN, Juliet Dreyer, RN MA, Bronya Calvarysky, MSc Clin Pharm, Sara Gechler, PhD, Alina Amitai, PharmD, Osnat Jarchowsky-Dolberg, MD, Giora Sharf, Eric Tousset, M.Sc., Opher Caspi, MDPhD, Martin Ellis, MD, Itai Levi, MD, Anat Gafter-Gvili, MD, Pia Raanani, MD
Journal: Blood
Blood (2015) 126 (23): 4034.
https://doi.org/10.1182/blood.V126.23.4034.4034
Published: 2015
Journal Articles

Factors Predicting Intentional Non-Adherence In Chronic Myeloid Leukemia: A Multivariate Analysis On 2546 Patients By The CML Advocates Network

Jan Geissler, Fabio Efficace, Felice Bombaci, Jan de Jong, Anthony Michael Gavin, Euzebiusz J Dziwinski, Mina Daban, Jana Pelouchová, Francesco Cottone, Joelle Guilhot, PhD, Giora Sharf
Journal: Blood
Blood (2013) 122 (21): 4023.
https://doi.org/10.1182/blood.V122.21.4023.4023
Published: 2013